U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Wed Apr 02 08:26:25 GMT 2025
Edited
by admin
on Wed Apr 02 08:26:25 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG2A
Sequence Origin MOUSE
Sequence Type COMPLETE
Record UNII
JGA39ICE2V
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MUROMONAB-CD3
INN   JAN   MART.   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
MUROMONAB CD3
MI  
Preferred Name English
OKT3
Code English
muromonab-cd3 [INN]
Common Name English
MUROMONAB CD3 [MI]
Common Name English
ORTHOCLONE OKT3
Brand Name English
PURIFIED IGG2A IMMUNOGLOBULIN MANUFACTURED INVOLVING FUSION OF MOUSE MYELOMA CELLS TO LYMPHOCYTES FROM IMMUNIZED ANIMALS TO PRODUCE A HYBRIDOMA WHICH SECRETES ANTIGEN-SPECIFIC ANTIBODIES TO THE T3 ANTIGEN OF HUMAN T-LYMPHOCYTES
Common Name English
MUROMONAB-CD3 [JAN]
Common Name English
MUROMONAB
Common Name English
OKT-3
Code English
L04AA02
Code English
Muromonab-cd3 [WHO-DD]
Common Name English
MUROMOMAB
Common Name English
MUROMONAB-CD3 [USAN]
Common Name English
ANTICD3
Common Name English
MUROMONAB-CD3 [MART.]
Common Name English
MUROMONAB-CD3 [VANDF]
Common Name English
MACS GMP CD3 PURE
Brand Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
NDF-RT N0000175620
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
WHO-VATC QL04AA02
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
WHO-ATC L04AA02
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
LIVERTOX NBK548590
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
NDF-RT N0000175550
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
NCI_THESAURUS C574
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
NDF-RT N0000175617
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
NDF-RT N0000175619
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
Code System Code Type Description
NCI_THESAURUS
C1321
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
PRIMARY
DRUG CENTRAL
5177
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
PRIMARY
RXCUI
42405
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
PRIMARY RxNorm
IUPHAR
6889
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
PRIMARY
USAN
Y-93
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
PRIMARY
INN
6281
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
PRIMARY
EVMPD
SUB129673
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
ALTERNATIVE
WIKIPEDIA
MUROMONAB-CD3
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
PRIMARY
CAS
140608-64-6
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
PRIMARY
MESH
D016853
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
PRIMARY
DRUG BANK
DB00075
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
PRIMARY
EVMPD
SUB03355MIG
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
PRIMARY
FDA UNII
JGA39ICE2V
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201608
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
PRIMARY
SMS_ID
100000091566
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
PRIMARY
MERCK INDEX
m7663
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
PRIMARY Merck Index
EPA CompTox
DTXSID2046414
Created by admin on Wed Apr 02 08:26:25 GMT 2025 , Edited by admin on Wed Apr 02 08:26:25 GMT 2025
PRIMARY
From To
4_133 4_193
4_23 4_87
2_370 2_428
2_264 2_324
2_134 2_201
2_105 4_213
2_22 2_96
1_370 1_428
1_264 1_324
1_232 2_232
1_229 2_229
1_223 2_223
1_134 1_201
1_105 3_213
1_22 1_96
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_300
N 2_300
Related Record Type Details
HIGH AFFINITY IMMUNOGLOBULIN GAMMA FC RECEPTOR I
TARGET -> AGONIST
CD3
CD3
TARGET -> INHIBITOR
Related Record Type Details
MUROMONAB-CD3
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO ACID SUBSTITUION [1_1] [2_1] GLUTAMINE PIDOLIC ACID SZB83O1W42
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:SEQUENCE(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966